Possible Correlation of Sirolimus Plasma Concentration with Sinusoidal Obstructive Syndrome of the Liver in Patients Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Possible Correlation of Sirolimus Plasma Concentration with Sinusoidal Obstructive Syndrome of the Liver in Patients Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation

Published:2012-04-12 Issue:5 Volume:32 Page:441-445
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Kiel Patrick J.¹,Vargo Craig A.²,Patel Gourang P.³,Rosenbeck Lindsay L.¹,Srivastava Shivani⁴

Affiliation:

1. Department of Pharmacy; Indiana University Simon Cancer Center; Indianapolis; Indiana

2. College of Pharmacy; Purdue University; West Lafayette; Indiana

3. Department of Pharmacy; Rush University Medical Center; Chicago; Illinois

4. Department of Medicine; Bone Marrow and Stem Cell Transplantation; Indiana University School of Medicine; Indianapolis; Indiana

Publisher

Wiley

Subject

Pharmacology (medical)

Reference15 articles.

1. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes;Morice;J Biol Chem,1993

2. Rapamycin inhibits IL-1-mediated interferon-gamma production in the YAC-1 T cell lymphoma;Altmeyer;Cytokine,1993

3. Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation;Cutler;Blood,2007

4. Sirolimus for the prevention of in-stent restenosis in a coronary artery;Marks;N Engl J Med,2003

5. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells;Matter;J Cardiovasc Pharmacol,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sinusoidal Obstruction Syndrome;Portal Hypertension - Recent Advances;2021-07-28

2. Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group;Transplantation;2020-12-01

3. Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome;Bone Marrow Transplantation;2020-07-04

4. Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors;Bone Marrow Transplantation;2020-05-05

5. Hepatic veno-occlusive disease following sirolimus-based immune suppression;Bone Marrow Transplantation;2018-06-12